Advertisement
ABBV or GSK or JNJ
ABBV | GSK | JNJ | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 90 | 61 | 57 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 16 Undervalued | 5 Undervalued | 12 Undervalued | |
PROFIT vs RISK RATING 1..100 | 4 | 52 | 6 | |
SMR RATING 1..100 | 1 | 34 | 37 | |
PRICE GROWTH RATING 1..100 | 55 | 60 | 49 | |
P/E GROWTH RATING 1..100 | 76 | 55 | 10 | |
SEASONALITY SCORE 1..100 | 50 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GSK's Valuation (5) in the Pharmaceuticals Major industry is in the same range as JNJ (12) and is in the same range as ABBV (16). This means that GSK's stock grew similarly to JNJ’s and similarly to ABBV’s over the last 12 months.
ABBV's Profit vs Risk Rating (4) in the Pharmaceuticals Major industry is in the same range as JNJ (6) and is somewhat better than the same rating for GSK (52). This means that ABBV's stock grew similarly to JNJ’s and somewhat faster than GSK’s over the last 12 months.
ABBV's SMR Rating (1) in the Pharmaceuticals Major industry is somewhat better than the same rating for GSK (34) and is somewhat better than the same rating for JNJ (37). This means that ABBV's stock grew somewhat faster than GSK’s and somewhat faster than JNJ’s over the last 12 months.
JNJ's Price Growth Rating (49) in the Pharmaceuticals Major industry is in the same range as ABBV (55) and is in the same range as GSK (60). This means that JNJ's stock grew similarly to ABBV’s and similarly to GSK’s over the last 12 months.
JNJ's P/E Growth Rating (10) in the Pharmaceuticals Major industry is somewhat better than the same rating for GSK (55) and is significantly better than the same rating for ABBV (76). This means that JNJ's stock grew somewhat faster than GSK’s and significantly faster than ABBV’s over the last 12 months.
| ABBV | GSK | JNJ | |
|---|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 64% | 1 day ago 33% |
| Stochastic ODDS (%) | 1 day ago 69% | 1 day ago 67% | 1 day ago 54% |
| Momentum ODDS (%) | 1 day ago 61% | 1 day ago 51% | 1 day ago 49% |
| MACD ODDS (%) | 1 day ago 45% | 1 day ago 46% | 1 day ago 43% |
| TrendWeek ODDS (%) | 1 day ago 63% | 1 day ago 54% | 1 day ago 40% |
| TrendMonth ODDS (%) | 1 day ago 64% | 1 day ago 53% | 1 day ago 44% |
| Advances ODDS (%) | 1 day ago 61% | 21 days ago 64% | 10 days ago 47% |
| Declines ODDS (%) | 7 days ago 46% | 3 days ago 55% | 3 days ago 40% |
| BollingerBands ODDS (%) | 1 day ago 54% | 1 day ago 70% | 1 day ago 47% |
| Aroon ODDS (%) | N/A | 1 day ago 46% | 1 day ago 38% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ABBV’s FA Score shows that 3 FA rating(s) are green while GSK’s FA Score has 1 green FA rating(s), and JNJ’s FA Score reflects 3 green FA rating(s).
- ABBV’s FA Score: 3 green, 2 red.
- GSK’s FA Score: 1 green, 4 red.
- JNJ’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ABBV’s TA Score shows that 5 TA indicator(s) are bullish while GSK’s TA Score has 4 bullish TA indicator(s), and JNJ’s TA Score reflects 4 bullish TA indicator(s).
- ABBV’s TA Score: 5 bullish, 2 bearish.
- GSK’s TA Score: 4 bullish, 7 bearish.
- JNJ’s TA Score: 4 bullish, 6 bearish.
Price Growth
ABBV (@Pharmaceuticals: Major) experienced а +1.29% price change this week, while GSK (@Pharmaceuticals: Major) price change was -5.57% , and JNJ (@Pharmaceuticals: Major) price fluctuated -4.78% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -3.44%. For the same industry, the average monthly price growth was -6.51%, and the average quarterly price growth was +7.41%.
Reported Earning Dates
ABBV is expected to report earnings on Oct 30, 2026.
GSK is expected to report earnings on Oct 28, 2026.
JNJ is expected to report earnings on Oct 13, 2026.
Industries' Descriptions
@Pharmaceuticals: Major (-3.44% weekly)The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
Advertisement
ABBV and
Correlation & Price change
A.I.dvisor indicates that over the last year, ABBV has been loosely correlated with BMY. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ABBV jumps, then BMY could also see price increases.
| Ticker / NAME | Correlation To ABBV | 1D Price Change % | ||
|---|---|---|---|---|
| ABBV | 100% | +0.35% | ||
| BMY - ABBV | 50% Loosely correlated | +1.33% | ||
| NVS - ABBV | 49% Loosely correlated | -0.10% | ||
| JNJ - ABBV | 48% Loosely correlated | +0.73% | ||
| AMGN - ABBV | 48% Loosely correlated | -0.09% | ||
| MRK - ABBV | 43% Loosely correlated | +1.72% | ||
More | ||||
GSK and
Correlation & Price change
A.I.dvisor indicates that over the last year, GSK has been loosely correlated with NVS. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if GSK jumps, then NVS could also see price increases.
JNJ and
Correlation & Price change
A.I.dvisor indicates that over the last year, JNJ has been loosely correlated with PFE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if JNJ jumps, then PFE could also see price increases.